Investing Profile

Myla Lai-Goldman

InvestorVC
Venture Partner at Hatteras Venture Partners
Photo of Myla Lai-Goldman, Venture Partner at Hatteras Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Pennsylvania Network
168 CONNECTIONS
University of Pennsylvania Network
168 CONNECTIONS
cb
$100K - $5.0M
$1.5M
$94M
Board Member Quanterix2025 - Present
Scientific Advisory Board Member Hitachi High-Tech America, Inc.2023 - Present
Board Member Mercy BioAnalytics, Inc.2023 - Present
Board Member NovoPath2022 - Present
Co-Founder and Chair GeneCentric2021 - Present
Co-Founder and Chair GeneCentric Diagnostics, Inc.2021 - Present
Board Member West Pharmaceutical Services2014 - Present
Venture Partner Hatteras Venture Partners2011 - Present
Managing Partner Personalized Science, LLC2009 - Present
Executive Chair Genecentric DiagnosticsPresent
Board Member Akoya Biosciences, Inc.2021 - 2025
Executive Chair GeneCentric2019 - 2021
Executive Chair GeneCentric Therapeutics, Inc2019 - 2021
Chief Executive Officer GeneCentric2011 - 2018
Chief Executive Officer GeneCentric Diagnostics, Inc.2011 - 2017
Executive VP, CMO & CSO Labcorp1998 - 2008
Pathologist, VP, SVP Labcorp1990 - 1998
Columbia University College of Physicians and Surgeons doctor of medicine, doctorates medicine
University of Pennsylvania Bachelor of Arts (B.A.) Biology, Concentration in Ecology
University of Pennsylvania bachelors, bachelor of arts biology, ecology